About Neo Pharm
We are leaders in the art & science of medicinal Cannabis.
We are focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis for conversion into medicinal cannabis oil for export and on the research and development of novel cannabinoid-based treatments for chronic pain as well as several central nervous system disorders, including fibromyalgia and irritable bowel syndrome.
Stay up to date on the research and development of novel cannabinoid-based treatments.
Our Mission & Vision
NEO PHARM aims to be one of the largest and fastest growing cannabis companies in Africa with a fully-funded production target of over 10,000 kilograms per year.
With the increasing adoption of medicinal cannabis legalisation globally, NEO PHARM is planning an aggressive Africa-wide expansion strategy and medium-term plans include producing value-added products along the pharmaceutical value chain via adoption of the farm-to-pharma business model.
Since the company’s formation in early 2019, it has focused its efforts on preparing for a successful operational launch in April 2021 in order to begin exporting quality Cannabis oil, and other related customer-specific products by the end of 2021.
It is the Holmes family’s “vision” to take an active role in our economic future by providing jobs and business opportunities for South Africans at the “working face,” and to create wealth from the “bottom up”. Our past activities in this regard have been substantial and will continue to be expansive.
Mr Les Holmes, chairman of the Holmes Group